These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 28579115)

  • 1. Bleeding and thrombosis associated with ventricular assist device therapy.
    Shah P; Tantry US; Bliden KP; Gurbel PA
    J Heart Lung Transplant; 2017 Nov; 36(11):1164-1173. PubMed ID: 28579115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and In Vitro Evidence That Left Ventricular Assist Device-Induced von Willebrand Factor Degradation Alters Angiogenesis.
    Bartoli CR; Zhang DM; Hennessy-Strahs S; Kang J; Restle DJ; Bermudez C; Atluri P; Acker MA
    Circ Heart Fail; 2018 Sep; 11(9):e004638. PubMed ID: 30354363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ambient hemolysis and activation of coagulation is different between HeartMate II and HeartWare left ventricular assist devices.
    Birschmann I; Dittrich M; Eller T; Wiegmann B; Reininger AJ; Budde U; Strüber M
    J Heart Lung Transplant; 2014 Jan; 33(1):80-7. PubMed ID: 24418734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of HeartWare ventricular assist device on the von Willebrand factor: results of an academic Belgian center.
    Esmaeilzadeh F; Wauters A; Wijns W; Argacha JF; van de Borne P
    BMC Cardiovasc Disord; 2016 Aug; 16(1):155. PubMed ID: 27485105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bleeding with the artificial heart: Gastrointestinal hemorrhage in CF-LVAD patients.
    Gurvits GE; Fradkov E
    World J Gastroenterol; 2017 Jun; 23(22):3945-3953. PubMed ID: 28652649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired coagulopathy in patients with left ventricular assist devices.
    Muslem R; Caliskan K; Leebeek FWG
    J Thromb Haemost; 2018 Mar; 16(3):429-440. PubMed ID: 29274191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low incidence of gastrointestinal bleeding and pump thrombosis in patients receiving the INCOR LVAD system in the long-term follow-up.
    Iacovoni A; Centofanti P; Attisani M; Verde A; Terzi A; Senni M; Maiani M; Baronetto A; Livi U; Frigerio M; Rinaldi M
    Int J Artif Organs; 2015 Oct; 38(10):542-7. PubMed ID: 26541278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Toroidal-Flow Left Ventricular Assist Device Minimizes Blood Trauma: Implications of Improved Ventricular Assist Device Hemocompatibility.
    Bartoli CR; Hennessy-Strahs S; Gohean J; Villeda M; Larson E; Longoria R; Kurusz M; Acker MA; Smalling R
    Ann Thorac Surg; 2019 Jun; 107(6):1761-1767. PubMed ID: 30586577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal bleeding and subsequent risk of thromboembolic events during support with a left ventricular assist device.
    Stulak JM; Lee D; Haft JW; Romano MA; Cowger JA; Park SJ; Aaronson KD; Pagani FD
    J Heart Lung Transplant; 2014 Jan; 33(1):60-4. PubMed ID: 24021944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preservation of von Willebrand factor multimers and function in patients with an EVAHEART centrifugal-type, continuous-flow left ventricular assist device.
    Ichihara Y; Nishinaka T; Komagamine M; Yamada Y; Yamazaki K
    J Heart Lung Transplant; 2017 Jul; 36(7):814-817. PubMed ID: 28495445
    [No Abstract]   [Full Text] [Related]  

  • 11. Intractable bleeding tendency due to acquired von Willebrand syndrome after Jarvik 2000 implant.
    Sakatsume K; Akiyama M; Saito K; Kawamoto S; Horiuchi H; Saiki Y
    J Artif Organs; 2016 Sep; 19(3):289-92. PubMed ID: 27021290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of ADAMTS-13 by Doxycycline Reduces von Willebrand Factor Degradation During Supraphysiological Shear Stress: Therapeutic Implications for Left Ventricular Assist Device-Associated Bleeding.
    Bartoli CR; Kang J; Restle DJ; Zhang DM; Shabahang C; Acker MA; Atluri P
    JACC Heart Fail; 2015 Nov; 3(11):860-9. PubMed ID: 26454844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombotic Strategies and Device Thrombosis.
    Gurbel PA; Shah P; Desai S; Tantry US
    Cardiol Clin; 2018 Nov; 36(4):541-550. PubMed ID: 30297071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention and Treatment of Thrombotic and Hemorrhagic Complications in Patients Supported by Continuous-Flow Left Ventricular Assist Devices.
    Loyaga-Rendon RY; Jani M; Fermin D; McDermott JK; Vancamp D; Lee S
    Curr Heart Fail Rep; 2017 Dec; 14(6):465-477. PubMed ID: 29075955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding Left Ventricular Assist Devices.
    Aissaoui N; Jouan J; Gourjault M; Diebold B; Ortuno S; Hamdan A; Latremouille C; Pirracchio R; Morshuis M
    Blood Purif; 2018; 46(4):292-300. PubMed ID: 30048974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematologic effects of continuous flow left ventricular assist devices.
    Slaughter MS
    J Cardiovasc Transl Res; 2010 Dec; 3(6):618-24. PubMed ID: 20835786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of echocardiography in patients with intravascular hemolysis due to suspected continuous-flow LVAD thrombosis.
    Fine NM; Topilsky Y; Oh JK; Hasin T; Kushwaha SS; Daly RC; Joyce LD; Stulak JM; Pereira NL; Boilson BA; Clavell AL; Edwards BS; Park SJ
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1129-40. PubMed ID: 24094831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased cyclic guanosine monophosphate levels and continuous-flow left-ventricular assist devices: Implications for gastrointestinal bleeding.
    Grosman-Rimon L; Tumiati LC; Fuks A; Jacobs I; Lalonde SD; Cherney DZ; Rao V
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):219-27. PubMed ID: 26515873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term discontinuation of antithrombotic therapy in patients with HeartMate II continuous-flow left ventricular assist device support.
    Schurr JW; Seifert FC; McLarty AJ
    Int J Artif Organs; 2019 Dec; 42(12):770-774. PubMed ID: 31298625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased RPM reduces von Willebrand factor degradation with the EVAHEART LVAS: implications for device-specific LVAD management.
    Bartoli CR; Kang J; Motomura T
    J Card Surg; 2020 Jul; 35(7):1477-1483. PubMed ID: 32652785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.